nodes	percent_of_prediction	percent_of_DWPC	metapath
Naproxen—AKR1C3—Doxorubicin—sarcoma	0.244	0.356	CbGbCtD
Naproxen—UGT2B7—Epirubicin—sarcoma	0.144	0.209	CbGbCtD
Naproxen—UGT1A1—Etoposide—sarcoma	0.0967	0.141	CbGbCtD
Naproxen—PTGS2—Etoposide—sarcoma	0.0581	0.0846	CbGbCtD
Naproxen—PTGS1—Etoposide—sarcoma	0.0491	0.0715	CbGbCtD
Naproxen—CYP1A2—Dacarbazine—sarcoma	0.0448	0.0652	CbGbCtD
Naproxen—CYP2C8—Etoposide—sarcoma	0.0283	0.0412	CbGbCtD
Naproxen—CYP1A2—Etoposide—sarcoma	0.0219	0.0319	CbGbCtD
Naproxen—AKR1C3—Podofilox—Etoposide—sarcoma	0.00346	0.592	CbGdCrCtD
Naproxen—PTGS2—periosteum—sarcoma	0.00268	0.0591	CbGeAlD
Naproxen—AKR1C3—Vinblastine—Vincristine—sarcoma	0.00238	0.408	CbGdCrCtD
Naproxen—PTGS2—leg—sarcoma	0.00214	0.0472	CbGeAlD
Naproxen—PTGS2—hindlimb—sarcoma	0.00191	0.0421	CbGeAlD
Naproxen—PTGS2—cartilage tissue—sarcoma	0.00188	0.0414	CbGeAlD
Naproxen—AKR1C3—myometrium—sarcoma	0.00167	0.0369	CbGeAlD
Naproxen—PTGS2—appendage—sarcoma	0.00164	0.0361	CbGeAlD
Naproxen—AKR1C3—seminal vesicle—sarcoma	0.00151	0.0333	CbGeAlD
Naproxen—ALB—mammary gland—sarcoma	0.00146	0.0323	CbGeAlD
Naproxen—UGT1A1—hematopoietic system—sarcoma	0.00132	0.0292	CbGeAlD
Naproxen—AKR1C3—smooth muscle tissue—sarcoma	0.00126	0.0279	CbGeAlD
Naproxen—AKR1C3—cardiac atrium—sarcoma	0.00109	0.024	CbGeAlD
Naproxen—AKR1C3—uterus—sarcoma	0.00108	0.0239	CbGeAlD
Naproxen—PTGS1—endothelium—sarcoma	0.00103	0.0228	CbGeAlD
Naproxen—CYP2C8—mammary gland—sarcoma	0.00103	0.0227	CbGeAlD
Naproxen—PTGS2—endothelium—sarcoma	0.000988	0.0218	CbGeAlD
Naproxen—AKR1C3—tendon—sarcoma	0.000949	0.021	CbGeAlD
Naproxen—AKR1C3—bone marrow—sarcoma	0.00092	0.0203	CbGeAlD
Naproxen—CYP2C9—mammary gland—sarcoma	0.000913	0.0201	CbGeAlD
Naproxen—SLCO1A2—hematopoietic system—sarcoma	0.000896	0.0198	CbGeAlD
Naproxen—UGT2B7—testis—sarcoma	0.000853	0.0188	CbGeAlD
Naproxen—UGT2B7—liver—sarcoma	0.000806	0.0178	CbGeAlD
Naproxen—AKR1C3—testis—sarcoma	0.000786	0.0174	CbGeAlD
Naproxen—AKR1C3—liver—sarcoma	0.000743	0.0164	CbGeAlD
Naproxen—UGT1A1—liver—sarcoma	0.000685	0.0151	CbGeAlD
Naproxen—CYP2C8—hematopoietic system—sarcoma	0.000626	0.0138	CbGeAlD
Naproxen—CYP1A2—hematopoietic system—sarcoma	0.000586	0.0129	CbGeAlD
Naproxen—AKR1C3—lymph node—sarcoma	0.00057	0.0126	CbGeAlD
Naproxen—PTGS2—myometrium—sarcoma	0.000565	0.0125	CbGeAlD
Naproxen—CYP2C9—hematopoietic system—sarcoma	0.000556	0.0123	CbGeAlD
Naproxen—PTGS2—embryo—sarcoma	0.000543	0.012	CbGeAlD
Naproxen—PTGS1—seminal vesicle—sarcoma	0.000534	0.0118	CbGeAlD
Naproxen—PTGS2—seminal vesicle—sarcoma	0.00051	0.0113	CbGeAlD
Naproxen—PTGS1—hematopoietic system—sarcoma	0.000508	0.0112	CbGeAlD
Naproxen—SLCO1A2—testis—sarcoma	0.000491	0.0108	CbGeAlD
Naproxen—PTGS1—connective tissue—sarcoma	0.000489	0.0108	CbGeAlD
Naproxen—ALB—testis—sarcoma	0.000488	0.0108	CbGeAlD
Naproxen—PTGS2—hematopoietic system—sarcoma	0.000485	0.0107	CbGeAlD
Naproxen—PTGS2—connective tissue—sarcoma	0.000467	0.0103	CbGeAlD
Naproxen—SLCO1A2—liver—sarcoma	0.000464	0.0102	CbGeAlD
Naproxen—ALB—liver—sarcoma	0.000461	0.0102	CbGeAlD
Naproxen—PTGS1—smooth muscle tissue—sarcoma	0.000447	0.00987	CbGeAlD
Naproxen—PTGS1—skin of body—sarcoma	0.000441	0.00974	CbGeAlD
Naproxen—PTGS2—smooth muscle tissue—sarcoma	0.000427	0.00943	CbGeAlD
Naproxen—PTGS2—skin of body—sarcoma	0.000422	0.00931	CbGeAlD
Naproxen—PTGS1—cardiac atrium—sarcoma	0.000385	0.00851	CbGeAlD
Naproxen—PTGS1—uterus—sarcoma	0.000383	0.00846	CbGeAlD
Naproxen—PTGS2—uterus—sarcoma	0.000366	0.00809	CbGeAlD
Naproxen—ALB—lymph node—sarcoma	0.000354	0.00781	CbGeAlD
Naproxen—CYP2C8—testis—sarcoma	0.000343	0.00757	CbGeAlD
Naproxen—PTGS2—lymphoid tissue—sarcoma	0.000342	0.00754	CbGeAlD
Naproxen—PTGS1—tendon—sarcoma	0.000336	0.00741	CbGeAlD
Naproxen—CYP2C8—liver—sarcoma	0.000324	0.00716	CbGeAlD
Naproxen—PTGS2—tendon—sarcoma	0.000321	0.00709	CbGeAlD
Naproxen—PTGS2—bone marrow—sarcoma	0.000311	0.00686	CbGeAlD
Naproxen—CYP1A2—liver—sarcoma	0.000303	0.0067	CbGeAlD
Naproxen—CYP2C9—liver—sarcoma	0.000288	0.00636	CbGeAlD
Naproxen—PTGS1—testis—sarcoma	0.000278	0.00614	CbGeAlD
Naproxen—PTGS2—liver—sarcoma	0.000251	0.00555	CbGeAlD
Naproxen—PTGS1—lymph node—sarcoma	0.000202	0.00445	CbGeAlD
Naproxen—PTGS2—lymph node—sarcoma	0.000193	0.00425	CbGeAlD
Naproxen—Angina pectoris—Doxorubicin—sarcoma	0.000156	0.000596	CcSEcCtD
Naproxen—Hypersensitivity—Mitoxantrone—sarcoma	0.000156	0.000594	CcSEcCtD
Naproxen—Asthenia—Vincristine—sarcoma	0.000156	0.000594	CcSEcCtD
Naproxen—Vomiting—Thiotepa—sarcoma	0.000156	0.000594	CcSEcCtD
Naproxen—Pneumonia—Epirubicin—sarcoma	0.000155	0.000593	CcSEcCtD
Naproxen—Drowsiness—Epirubicin—sarcoma	0.000154	0.00059	CcSEcCtD
Naproxen—Vomiting—Dactinomycin—sarcoma	0.000154	0.000589	CcSEcCtD
Naproxen—Rash—Thiotepa—sarcoma	0.000154	0.000589	CcSEcCtD
Naproxen—Bronchitis—Doxorubicin—sarcoma	0.000154	0.000588	CcSEcCtD
Naproxen—Dermatitis—Thiotepa—sarcoma	0.000154	0.000588	CcSEcCtD
Naproxen—Headache—Thiotepa—sarcoma	0.000153	0.000585	CcSEcCtD
Naproxen—Stevens-Johnson syndrome—Epirubicin—sarcoma	0.000153	0.000585	CcSEcCtD
Naproxen—Rash—Dactinomycin—sarcoma	0.000153	0.000584	CcSEcCtD
Naproxen—Decreased appetite—Etoposide—sarcoma	0.000153	0.000583	CcSEcCtD
Naproxen—Pancytopenia—Doxorubicin—sarcoma	0.000152	0.000581	CcSEcCtD
Naproxen—Renal failure—Epirubicin—sarcoma	0.000152	0.00058	CcSEcCtD
Naproxen—Gastrointestinal disorder—Etoposide—sarcoma	0.000152	0.000579	CcSEcCtD
Naproxen—Asthenia—Mitoxantrone—sarcoma	0.000152	0.000579	CcSEcCtD
Naproxen—Fatigue—Etoposide—sarcoma	0.000151	0.000578	CcSEcCtD
Naproxen—Neuropathy peripheral—Epirubicin—sarcoma	0.000151	0.000578	CcSEcCtD
Naproxen—Stomatitis—Epirubicin—sarcoma	0.000151	0.000575	CcSEcCtD
Naproxen—Jaundice—Epirubicin—sarcoma	0.000151	0.000575	CcSEcCtD
Naproxen—Constipation—Etoposide—sarcoma	0.00015	0.000574	CcSEcCtD
Naproxen—Pain—Etoposide—sarcoma	0.00015	0.000574	CcSEcCtD
Naproxen—Conjunctivitis—Epirubicin—sarcoma	0.00015	0.000573	CcSEcCtD
Naproxen—Urinary tract infection—Epirubicin—sarcoma	0.00015	0.000573	CcSEcCtD
Naproxen—Dysuria—Doxorubicin—sarcoma	0.00015	0.000572	CcSEcCtD
Naproxen—Diarrhoea—Vincristine—sarcoma	0.000148	0.000567	CcSEcCtD
Naproxen—Sweating—Epirubicin—sarcoma	0.000148	0.000565	CcSEcCtD
Naproxen—Pollakiuria—Doxorubicin—sarcoma	0.000148	0.000565	CcSEcCtD
Naproxen—Haematuria—Epirubicin—sarcoma	0.000147	0.000562	CcSEcCtD
Naproxen—Photosensitivity reaction—Doxorubicin—sarcoma	0.000146	0.000559	CcSEcCtD
Naproxen—Hepatobiliary disease—Epirubicin—sarcoma	0.000146	0.000558	CcSEcCtD
Naproxen—Epistaxis—Epirubicin—sarcoma	0.000146	0.000556	CcSEcCtD
Naproxen—Nausea—Thiotepa—sarcoma	0.000145	0.000555	CcSEcCtD
Naproxen—Weight decreased—Doxorubicin—sarcoma	0.000145	0.000554	CcSEcCtD
Naproxen—Sinusitis—Epirubicin—sarcoma	0.000145	0.000553	CcSEcCtD
Naproxen—Feeling abnormal—Etoposide—sarcoma	0.000145	0.000553	CcSEcCtD
Naproxen—Hyperglycaemia—Doxorubicin—sarcoma	0.000145	0.000552	CcSEcCtD
Naproxen—Diarrhoea—Mitoxantrone—sarcoma	0.000145	0.000552	CcSEcCtD
Naproxen—Nausea—Dactinomycin—sarcoma	0.000144	0.000551	CcSEcCtD
Naproxen—Agranulocytosis—Epirubicin—sarcoma	0.000144	0.00055	CcSEcCtD
Naproxen—Pneumonia—Doxorubicin—sarcoma	0.000144	0.000549	CcSEcCtD
Naproxen—Gastrointestinal pain—Etoposide—sarcoma	0.000144	0.000549	CcSEcCtD
Naproxen—Dizziness—Vincristine—sarcoma	0.000143	0.000548	CcSEcCtD
Naproxen—Drowsiness—Doxorubicin—sarcoma	0.000143	0.000546	CcSEcCtD
Naproxen—Stevens-Johnson syndrome—Doxorubicin—sarcoma	0.000142	0.000541	CcSEcCtD
Naproxen—Renal failure—Doxorubicin—sarcoma	0.00014	0.000536	CcSEcCtD
Naproxen—Neuropathy peripheral—Doxorubicin—sarcoma	0.00014	0.000535	CcSEcCtD
Naproxen—Urticaria—Etoposide—sarcoma	0.00014	0.000533	CcSEcCtD
Naproxen—Haemoglobin—Epirubicin—sarcoma	0.000139	0.000532	CcSEcCtD
Naproxen—Stomatitis—Doxorubicin—sarcoma	0.000139	0.000532	CcSEcCtD
Naproxen—Jaundice—Doxorubicin—sarcoma	0.000139	0.000532	CcSEcCtD
Naproxen—Rhinitis—Epirubicin—sarcoma	0.000139	0.000531	CcSEcCtD
Naproxen—Abdominal pain—Etoposide—sarcoma	0.000139	0.00053	CcSEcCtD
Naproxen—Body temperature increased—Etoposide—sarcoma	0.000139	0.00053	CcSEcCtD
Naproxen—Conjunctivitis—Doxorubicin—sarcoma	0.000139	0.00053	CcSEcCtD
Naproxen—Urinary tract infection—Doxorubicin—sarcoma	0.000139	0.00053	CcSEcCtD
Naproxen—Hepatitis—Epirubicin—sarcoma	0.000139	0.000529	CcSEcCtD
Naproxen—Haemorrhage—Epirubicin—sarcoma	0.000139	0.000529	CcSEcCtD
Naproxen—Vomiting—Vincristine—sarcoma	0.000138	0.000527	CcSEcCtD
Naproxen—Pharyngitis—Epirubicin—sarcoma	0.000138	0.000525	CcSEcCtD
Naproxen—Sweating—Doxorubicin—sarcoma	0.000137	0.000523	CcSEcCtD
Naproxen—Urinary tract disorder—Epirubicin—sarcoma	0.000137	0.000523	CcSEcCtD
Naproxen—Rash—Vincristine—sarcoma	0.000137	0.000522	CcSEcCtD
Naproxen—Dermatitis—Vincristine—sarcoma	0.000137	0.000522	CcSEcCtD
Naproxen—Oedema peripheral—Epirubicin—sarcoma	0.000137	0.000521	CcSEcCtD
Naproxen—Haematuria—Doxorubicin—sarcoma	0.000136	0.00052	CcSEcCtD
Naproxen—Connective tissue disorder—Epirubicin—sarcoma	0.000136	0.00052	CcSEcCtD
Naproxen—Urethral disorder—Epirubicin—sarcoma	0.000136	0.000519	CcSEcCtD
Naproxen—Headache—Vincristine—sarcoma	0.000136	0.000519	CcSEcCtD
Naproxen—Hepatobiliary disease—Doxorubicin—sarcoma	0.000135	0.000516	CcSEcCtD
Naproxen—Epistaxis—Doxorubicin—sarcoma	0.000135	0.000515	CcSEcCtD
Naproxen—Vomiting—Mitoxantrone—sarcoma	0.000134	0.000513	CcSEcCtD
Naproxen—Sinusitis—Doxorubicin—sarcoma	0.000134	0.000512	CcSEcCtD
Naproxen—Visual impairment—Epirubicin—sarcoma	0.000134	0.00051	CcSEcCtD
Naproxen—Agranulocytosis—Doxorubicin—sarcoma	0.000133	0.000509	CcSEcCtD
Naproxen—Rash—Mitoxantrone—sarcoma	0.000133	0.000509	CcSEcCtD
Naproxen—Dermatitis—Mitoxantrone—sarcoma	0.000133	0.000508	CcSEcCtD
Naproxen—Headache—Mitoxantrone—sarcoma	0.000132	0.000505	CcSEcCtD
Naproxen—Erythema multiforme—Epirubicin—sarcoma	0.000131	0.0005	CcSEcCtD
Naproxen—Eye disorder—Epirubicin—sarcoma	0.00013	0.000495	CcSEcCtD
Naproxen—Hypersensitivity—Etoposide—sarcoma	0.000129	0.000494	CcSEcCtD
Naproxen—Tinnitus—Epirubicin—sarcoma	0.000129	0.000494	CcSEcCtD
Naproxen—Haemoglobin—Doxorubicin—sarcoma	0.000129	0.000492	CcSEcCtD
Naproxen—Nausea—Vincristine—sarcoma	0.000129	0.000492	CcSEcCtD
Naproxen—Cardiac disorder—Epirubicin—sarcoma	0.000129	0.000491	CcSEcCtD
Naproxen—Rhinitis—Doxorubicin—sarcoma	0.000129	0.000491	CcSEcCtD
Naproxen—Haemorrhage—Doxorubicin—sarcoma	0.000128	0.00049	CcSEcCtD
Naproxen—Hepatitis—Doxorubicin—sarcoma	0.000128	0.00049	CcSEcCtD
Naproxen—Pharyngitis—Doxorubicin—sarcoma	0.000127	0.000486	CcSEcCtD
Naproxen—Urinary tract disorder—Doxorubicin—sarcoma	0.000127	0.000484	CcSEcCtD
Naproxen—Oedema peripheral—Doxorubicin—sarcoma	0.000126	0.000482	CcSEcCtD
Naproxen—Asthenia—Etoposide—sarcoma	0.000126	0.000481	CcSEcCtD
Naproxen—Connective tissue disorder—Doxorubicin—sarcoma	0.000126	0.000481	CcSEcCtD
Naproxen—Angiopathy—Epirubicin—sarcoma	0.000126	0.00048	CcSEcCtD
Naproxen—Urethral disorder—Doxorubicin—sarcoma	0.000126	0.00048	CcSEcCtD
Naproxen—Nausea—Mitoxantrone—sarcoma	0.000125	0.000479	CcSEcCtD
Naproxen—Immune system disorder—Epirubicin—sarcoma	0.000125	0.000478	CcSEcCtD
Naproxen—Mediastinal disorder—Epirubicin—sarcoma	0.000125	0.000477	CcSEcCtD
Naproxen—Chills—Epirubicin—sarcoma	0.000124	0.000475	CcSEcCtD
Naproxen—Pruritus—Etoposide—sarcoma	0.000124	0.000475	CcSEcCtD
Naproxen—Arrhythmia—Epirubicin—sarcoma	0.000124	0.000473	CcSEcCtD
Naproxen—Visual impairment—Doxorubicin—sarcoma	0.000124	0.000472	CcSEcCtD
Naproxen—Alopecia—Epirubicin—sarcoma	0.000122	0.000468	CcSEcCtD
Naproxen—Mental disorder—Epirubicin—sarcoma	0.000121	0.000464	CcSEcCtD
Naproxen—Erythema multiforme—Doxorubicin—sarcoma	0.000121	0.000463	CcSEcCtD
Naproxen—Malnutrition—Epirubicin—sarcoma	0.000121	0.000461	CcSEcCtD
Naproxen—Erythema—Epirubicin—sarcoma	0.000121	0.000461	CcSEcCtD
Naproxen—Diarrhoea—Etoposide—sarcoma	0.00012	0.000459	CcSEcCtD
Naproxen—Eye disorder—Doxorubicin—sarcoma	0.00012	0.000458	CcSEcCtD
Naproxen—Tinnitus—Doxorubicin—sarcoma	0.00012	0.000457	CcSEcCtD
Naproxen—Cardiac disorder—Doxorubicin—sarcoma	0.000119	0.000455	CcSEcCtD
Naproxen—Flatulence—Epirubicin—sarcoma	0.000119	0.000454	CcSEcCtD
Naproxen—Tension—Epirubicin—sarcoma	0.000118	0.000452	CcSEcCtD
Naproxen—Nervousness—Epirubicin—sarcoma	0.000117	0.000448	CcSEcCtD
Naproxen—Angiopathy—Doxorubicin—sarcoma	0.000116	0.000444	CcSEcCtD
Naproxen—Dizziness—Etoposide—sarcoma	0.000116	0.000444	CcSEcCtD
Naproxen—Muscle spasms—Epirubicin—sarcoma	0.000116	0.000443	CcSEcCtD
Naproxen—Immune system disorder—Doxorubicin—sarcoma	0.000116	0.000442	CcSEcCtD
Naproxen—Mediastinal disorder—Doxorubicin—sarcoma	0.000116	0.000441	CcSEcCtD
Naproxen—Chills—Doxorubicin—sarcoma	0.000115	0.000439	CcSEcCtD
Naproxen—Arrhythmia—Doxorubicin—sarcoma	0.000115	0.000438	CcSEcCtD
Naproxen—Vision blurred—Epirubicin—sarcoma	0.000114	0.000434	CcSEcCtD
Naproxen—Alopecia—Doxorubicin—sarcoma	0.000113	0.000433	CcSEcCtD
Naproxen—Mental disorder—Doxorubicin—sarcoma	0.000112	0.000429	CcSEcCtD
Naproxen—Ill-defined disorder—Epirubicin—sarcoma	0.000112	0.000428	CcSEcCtD
Naproxen—Vomiting—Etoposide—sarcoma	0.000112	0.000427	CcSEcCtD
Naproxen—Erythema—Doxorubicin—sarcoma	0.000112	0.000426	CcSEcCtD
Naproxen—Malnutrition—Doxorubicin—sarcoma	0.000112	0.000426	CcSEcCtD
Naproxen—Anaemia—Epirubicin—sarcoma	0.000112	0.000426	CcSEcCtD
Naproxen—Rash—Etoposide—sarcoma	0.000111	0.000423	CcSEcCtD
Naproxen—Dermatitis—Etoposide—sarcoma	0.000111	0.000423	CcSEcCtD
Naproxen—Headache—Etoposide—sarcoma	0.00011	0.00042	CcSEcCtD
Naproxen—Flatulence—Doxorubicin—sarcoma	0.00011	0.00042	CcSEcCtD
Naproxen—Tension—Doxorubicin—sarcoma	0.00011	0.000418	CcSEcCtD
Naproxen—Malaise—Epirubicin—sarcoma	0.000109	0.000416	CcSEcCtD
Naproxen—Nervousness—Doxorubicin—sarcoma	0.000108	0.000414	CcSEcCtD
Naproxen—Vertigo—Epirubicin—sarcoma	0.000108	0.000414	CcSEcCtD
Naproxen—Syncope—Epirubicin—sarcoma	0.000108	0.000413	CcSEcCtD
Naproxen—Leukopenia—Epirubicin—sarcoma	0.000108	0.000412	CcSEcCtD
Naproxen—Muscle spasms—Doxorubicin—sarcoma	0.000107	0.00041	CcSEcCtD
Naproxen—Palpitations—Epirubicin—sarcoma	0.000107	0.000407	CcSEcCtD
Naproxen—Loss of consciousness—Epirubicin—sarcoma	0.000106	0.000405	CcSEcCtD
Naproxen—Cough—Epirubicin—sarcoma	0.000105	0.000402	CcSEcCtD
Naproxen—Vision blurred—Doxorubicin—sarcoma	0.000105	0.000402	CcSEcCtD
Naproxen—Convulsion—Epirubicin—sarcoma	0.000105	0.000399	CcSEcCtD
Naproxen—Nausea—Etoposide—sarcoma	0.000104	0.000398	CcSEcCtD
Naproxen—Hypertension—Epirubicin—sarcoma	0.000104	0.000398	CcSEcCtD
Naproxen—Ill-defined disorder—Doxorubicin—sarcoma	0.000104	0.000396	CcSEcCtD
Naproxen—Anaemia—Doxorubicin—sarcoma	0.000103	0.000394	CcSEcCtD
Naproxen—Chest pain—Epirubicin—sarcoma	0.000103	0.000392	CcSEcCtD
Naproxen—Myalgia—Epirubicin—sarcoma	0.000103	0.000392	CcSEcCtD
Naproxen—Arthralgia—Epirubicin—sarcoma	0.000103	0.000392	CcSEcCtD
Naproxen—Anxiety—Epirubicin—sarcoma	0.000102	0.000391	CcSEcCtD
Naproxen—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—sarcoma	0.000102	0.00039	CcSEcCtD
Naproxen—Discomfort—Epirubicin—sarcoma	0.000102	0.000388	CcSEcCtD
Naproxen—Malaise—Doxorubicin—sarcoma	0.000101	0.000384	CcSEcCtD
Naproxen—Dry mouth—Epirubicin—sarcoma	0.0001	0.000384	CcSEcCtD
Naproxen—Vertigo—Doxorubicin—sarcoma	0.0001	0.000383	CcSEcCtD
Naproxen—Syncope—Doxorubicin—sarcoma	0.0001	0.000382	CcSEcCtD
Naproxen—Leukopenia—Doxorubicin—sarcoma	9.99e-05	0.000382	CcSEcCtD
Naproxen—Confusional state—Epirubicin—sarcoma	9.93e-05	0.000379	CcSEcCtD
Naproxen—Palpitations—Doxorubicin—sarcoma	9.87e-05	0.000377	CcSEcCtD
Naproxen—Anaphylactic shock—Epirubicin—sarcoma	9.85e-05	0.000376	CcSEcCtD
Naproxen—Oedema—Epirubicin—sarcoma	9.85e-05	0.000376	CcSEcCtD
Naproxen—Loss of consciousness—Doxorubicin—sarcoma	9.81e-05	0.000375	CcSEcCtD
Naproxen—Infection—Epirubicin—sarcoma	9.78e-05	0.000374	CcSEcCtD
Naproxen—Cough—Doxorubicin—sarcoma	9.74e-05	0.000372	CcSEcCtD
Naproxen—Shock—Epirubicin—sarcoma	9.69e-05	0.00037	CcSEcCtD
Naproxen—Convulsion—Doxorubicin—sarcoma	9.67e-05	0.000369	CcSEcCtD
Naproxen—Nervous system disorder—Epirubicin—sarcoma	9.66e-05	0.000369	CcSEcCtD
Naproxen—Thrombocytopenia—Epirubicin—sarcoma	9.64e-05	0.000368	CcSEcCtD
Naproxen—Hypertension—Doxorubicin—sarcoma	9.64e-05	0.000368	CcSEcCtD
Naproxen—Tachycardia—Epirubicin—sarcoma	9.61e-05	0.000367	CcSEcCtD
Naproxen—Skin disorder—Epirubicin—sarcoma	9.57e-05	0.000365	CcSEcCtD
Naproxen—Hyperhidrosis—Epirubicin—sarcoma	9.52e-05	0.000364	CcSEcCtD
Naproxen—Arthralgia—Doxorubicin—sarcoma	9.51e-05	0.000363	CcSEcCtD
Naproxen—Myalgia—Doxorubicin—sarcoma	9.51e-05	0.000363	CcSEcCtD
Naproxen—Chest pain—Doxorubicin—sarcoma	9.51e-05	0.000363	CcSEcCtD
Naproxen—Anxiety—Doxorubicin—sarcoma	9.47e-05	0.000362	CcSEcCtD
Naproxen—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—sarcoma	9.44e-05	0.00036	CcSEcCtD
Naproxen—Discomfort—Doxorubicin—sarcoma	9.39e-05	0.000359	CcSEcCtD
Naproxen—Anorexia—Epirubicin—sarcoma	9.39e-05	0.000358	CcSEcCtD
Naproxen—Dry mouth—Doxorubicin—sarcoma	9.3e-05	0.000355	CcSEcCtD
Naproxen—Hypotension—Epirubicin—sarcoma	9.2e-05	0.000351	CcSEcCtD
Naproxen—Confusional state—Doxorubicin—sarcoma	9.19e-05	0.000351	CcSEcCtD
Naproxen—Anaphylactic shock—Doxorubicin—sarcoma	9.11e-05	0.000348	CcSEcCtD
Naproxen—Oedema—Doxorubicin—sarcoma	9.11e-05	0.000348	CcSEcCtD
Naproxen—Infection—Doxorubicin—sarcoma	9.05e-05	0.000346	CcSEcCtD
Naproxen—Musculoskeletal discomfort—Epirubicin—sarcoma	8.97e-05	0.000343	CcSEcCtD
Naproxen—Shock—Doxorubicin—sarcoma	8.97e-05	0.000342	CcSEcCtD
Naproxen—Nervous system disorder—Doxorubicin—sarcoma	8.94e-05	0.000341	CcSEcCtD
Naproxen—Thrombocytopenia—Doxorubicin—sarcoma	8.92e-05	0.000341	CcSEcCtD
Naproxen—Insomnia—Epirubicin—sarcoma	8.91e-05	0.00034	CcSEcCtD
Naproxen—Tachycardia—Doxorubicin—sarcoma	8.89e-05	0.00034	CcSEcCtD
Naproxen—Skin disorder—Doxorubicin—sarcoma	8.85e-05	0.000338	CcSEcCtD
Naproxen—Paraesthesia—Epirubicin—sarcoma	8.84e-05	0.000338	CcSEcCtD
Naproxen—Hyperhidrosis—Doxorubicin—sarcoma	8.81e-05	0.000336	CcSEcCtD
Naproxen—Dyspnoea—Epirubicin—sarcoma	8.78e-05	0.000335	CcSEcCtD
Naproxen—Somnolence—Epirubicin—sarcoma	8.76e-05	0.000334	CcSEcCtD
Naproxen—Anorexia—Doxorubicin—sarcoma	8.69e-05	0.000332	CcSEcCtD
Naproxen—Dyspepsia—Epirubicin—sarcoma	8.67e-05	0.000331	CcSEcCtD
Naproxen—Decreased appetite—Epirubicin—sarcoma	8.56e-05	0.000327	CcSEcCtD
Naproxen—Hypotension—Doxorubicin—sarcoma	8.52e-05	0.000325	CcSEcCtD
Naproxen—Gastrointestinal disorder—Epirubicin—sarcoma	8.5e-05	0.000325	CcSEcCtD
Naproxen—Fatigue—Epirubicin—sarcoma	8.49e-05	0.000324	CcSEcCtD
Naproxen—Pain—Epirubicin—sarcoma	8.42e-05	0.000322	CcSEcCtD
Naproxen—Constipation—Epirubicin—sarcoma	8.42e-05	0.000322	CcSEcCtD
Naproxen—Musculoskeletal discomfort—Doxorubicin—sarcoma	8.3e-05	0.000317	CcSEcCtD
Naproxen—Insomnia—Doxorubicin—sarcoma	8.24e-05	0.000315	CcSEcCtD
Naproxen—Paraesthesia—Doxorubicin—sarcoma	8.18e-05	0.000312	CcSEcCtD
Naproxen—Dyspnoea—Doxorubicin—sarcoma	8.12e-05	0.00031	CcSEcCtD
Naproxen—Feeling abnormal—Epirubicin—sarcoma	8.12e-05	0.00031	CcSEcCtD
Naproxen—Somnolence—Doxorubicin—sarcoma	8.1e-05	0.000309	CcSEcCtD
Naproxen—Gastrointestinal pain—Epirubicin—sarcoma	8.05e-05	0.000308	CcSEcCtD
Naproxen—Dyspepsia—Doxorubicin—sarcoma	8.02e-05	0.000306	CcSEcCtD
Naproxen—Decreased appetite—Doxorubicin—sarcoma	7.92e-05	0.000302	CcSEcCtD
Naproxen—Gastrointestinal disorder—Doxorubicin—sarcoma	7.87e-05	0.0003	CcSEcCtD
Naproxen—Fatigue—Doxorubicin—sarcoma	7.86e-05	0.0003	CcSEcCtD
Naproxen—Urticaria—Epirubicin—sarcoma	7.82e-05	0.000299	CcSEcCtD
Naproxen—Pain—Doxorubicin—sarcoma	7.79e-05	0.000298	CcSEcCtD
Naproxen—Constipation—Doxorubicin—sarcoma	7.79e-05	0.000298	CcSEcCtD
Naproxen—Abdominal pain—Epirubicin—sarcoma	7.79e-05	0.000297	CcSEcCtD
Naproxen—Body temperature increased—Epirubicin—sarcoma	7.79e-05	0.000297	CcSEcCtD
Naproxen—Feeling abnormal—Doxorubicin—sarcoma	7.51e-05	0.000287	CcSEcCtD
Naproxen—Gastrointestinal pain—Doxorubicin—sarcoma	7.45e-05	0.000285	CcSEcCtD
Naproxen—Hypersensitivity—Epirubicin—sarcoma	7.26e-05	0.000277	CcSEcCtD
Naproxen—Urticaria—Doxorubicin—sarcoma	7.24e-05	0.000276	CcSEcCtD
Naproxen—Body temperature increased—Doxorubicin—sarcoma	7.2e-05	0.000275	CcSEcCtD
Naproxen—Abdominal pain—Doxorubicin—sarcoma	7.2e-05	0.000275	CcSEcCtD
Naproxen—Asthenia—Epirubicin—sarcoma	7.07e-05	0.00027	CcSEcCtD
Naproxen—Pruritus—Epirubicin—sarcoma	6.97e-05	0.000266	CcSEcCtD
Naproxen—Diarrhoea—Epirubicin—sarcoma	6.74e-05	0.000257	CcSEcCtD
Naproxen—Hypersensitivity—Doxorubicin—sarcoma	6.71e-05	0.000256	CcSEcCtD
Naproxen—Asthenia—Doxorubicin—sarcoma	6.54e-05	0.00025	CcSEcCtD
Naproxen—Dizziness—Epirubicin—sarcoma	6.51e-05	0.000249	CcSEcCtD
Naproxen—Pruritus—Doxorubicin—sarcoma	6.45e-05	0.000246	CcSEcCtD
Naproxen—Vomiting—Epirubicin—sarcoma	6.26e-05	0.000239	CcSEcCtD
Naproxen—Diarrhoea—Doxorubicin—sarcoma	6.23e-05	0.000238	CcSEcCtD
Naproxen—Rash—Epirubicin—sarcoma	6.21e-05	0.000237	CcSEcCtD
Naproxen—Dermatitis—Epirubicin—sarcoma	6.2e-05	0.000237	CcSEcCtD
Naproxen—Headache—Epirubicin—sarcoma	6.17e-05	0.000236	CcSEcCtD
Naproxen—Dizziness—Doxorubicin—sarcoma	6.03e-05	0.00023	CcSEcCtD
Naproxen—Nausea—Epirubicin—sarcoma	5.85e-05	0.000223	CcSEcCtD
Naproxen—Vomiting—Doxorubicin—sarcoma	5.79e-05	0.000221	CcSEcCtD
Naproxen—Rash—Doxorubicin—sarcoma	5.75e-05	0.000219	CcSEcCtD
Naproxen—Dermatitis—Doxorubicin—sarcoma	5.74e-05	0.000219	CcSEcCtD
Naproxen—Headache—Doxorubicin—sarcoma	5.71e-05	0.000218	CcSEcCtD
Naproxen—Nausea—Doxorubicin—sarcoma	5.41e-05	0.000207	CcSEcCtD
